Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.
2.

Human fetal hippocampal development: II. The neuronal cytoskeleton.

Arnold SE, Trojanowski JQ.

J Comp Neurol. 1996 Apr 1;367(2):293-307.

PMID:
8708011
3.

Alterations in hippocampal non-phosphorylated MAP2 protein expression in schizophrenia.

Cotter D, Kerwin R, Doshi B, Martin CS, Everall IP.

Brain Res. 1997 Aug 15;765(2):238-46.

PMID:
9313896
4.

Aberrant localization of MAP5 immunoreactivity in the hippocampal formation in Alzheimer's disease.

Geddes JW, Lundgren K, Kim YK.

J Neurosci Res. 1991 Sep;30(1):183-91.

PMID:
1795403
5.

Microtubule-associated protein MAP2 expression in olfactory bulb in schizophrenia.

Rioux L, Ruscheinsky D, Arnold SE.

Psychiatry Res. 2004 Aug 30;128(1):1-7.

PMID:
15450909
6.
7.

The neuronal cytoskeleton as a potential therapeutical target in neurodegenerative diseases and schizophrenia.

Benitez-King G, Ramírez-Rodríguez G, Ortíz L, Meza I.

Curr Drug Targets CNS Neurol Disord. 2004 Dec;3(6):515-33. Review.

PMID:
15581421
8.

Cellular and molecular neuropathology of the parahippocampal region in schizophrenia.

Arnold SE.

Ann N Y Acad Sci. 2000 Jun;911:275-92. Review.

PMID:
10911880
9.
10.

Abnormalities of Wnt signalling in schizophrenia--evidence for neurodevelopmental abnormality.

Cotter D, Kerwin R, al-Sarraji S, Brion JP, Chadwich A, Lovestone S, Anderton B, Everall I.

Neuroreport. 1998 May 11;9(7):1379-83.

PMID:
9631433
11.
12.
13.

Effect of hypothermia on postmortem alterations in MAP2 immunostaining in the human hippocampus.

Kitamura O, Gotohda T, Ishigami A, Tokunaga I, Kubo S, Nakasono I.

Leg Med (Tokyo). 2005 Jan;7(1):24-30. Erratum in: Leg Med (Tokyo). 2005 Oct;7(5):339. Corrected and republished in: Leg Med (Tokyo). 2005 Oct;7(5):340-344.

PMID:
15556012
14.

Hippocampal complexin proteins and cognitive dysfunction in schizophrenia.

Sawada K, Barr AM, Nakamura M, Arima K, Young CE, Dwork AJ, Falkai P, Phillips AG, Honer WG.

Arch Gen Psychiatry. 2005 Mar;62(3):263-72.

PMID:
15753239
15.

Differential interactions of MAP2, tau and MAP5 during axogenesis in culture.

Kwei SL, Clement A, Faissner A, Brandt R.

Neuroreport. 1998 Apr 20;9(6):1035-40.

PMID:
9601663
16.

Loss of synaptic but not cytoskeletal proteins in the cerebellum of chronic schizophrenics.

Mukaetova-Ladinska E, Hurt J, Honer WG, Harrington CR, Wischik CM.

Neurosci Lett. 2002 Jan 14;317(3):161-5.

PMID:
11755264
17.
18.

Alterations in neurofilament protein immunoreactivity in human hippocampal neurons related to normal aging and Alzheimer's disease.

Vickers JC, Riederer BM, Marugg RA, Buée-Scherrer V, Buée L, Delacourte A, Morrison JH.

Neuroscience. 1994 Sep;62(1):1-13.

PMID:
7816192
19.

Distribution and gene expression of cytoskeletal proteins in two-cell rat embryos and developmental arrest.

Matsumoto H, Jiang JY, Mitani D, Sato E.

J Exp Zool. 2002 Dec 1;293(7):641-8.

PMID:
12410592

Supplemental Content

Support Center